Updates on the Treatment of Essential Hypertension: A Summary of AHRQ’s Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Direct Renin Inhibitors
Journal of Managed Care Pharmacy
doi 10.18553/jmcp.2011.17.s8.1
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2011
Authors
Publisher
Academy of Managed Care Pharmacy